![](/img/cover-not-exists.png)
Urinary F2-Isoprostanes Are Not Associated with Increased Risk of Type 2 Diabetes
Dora Il'yasova, Jason D. Morrow, Lynne E. WagenknechtVolume:
13
Year:
2005
Language:
english
Pages:
7
DOI:
10.1038/oby.2005.201
File:
PDF, 140 KB
english, 2005